The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials

References

• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612 69 9021296855
   PubMed Web of Science ®Google Scholar
• HerbstRSHeymachJVLippmanSMLung cancerN Engl J Med200835913 1367 138018815398
   PubMed Web of Science ®Google Scholar
• ShepherdFAScreening, diagnosis, and staging of lung cancerCurr Opin Oncol199352 310 3228384493
   PubMedGoogle Scholar
• SchillerJHHarringtonDBelaniCPEastern Cooperative Oncology GroupComparison of four chemotherapy regimens for advanced non-small-cell lung cancerN Engl J Med20023462 92 9811784875
   PubMed Web of Science ®Google Scholar
• GeorgouliasVArdavanisAAgelidouADocetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trialJ Clin Oncol20042213 2602 260915226327
   PubMed Web of Science ®Google Scholar
• RinoYYukawaNSatoTPhase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancerMol Clin Oncol201314 749 75224649240
   PubMedGoogle Scholar
• GenestretiGDi BattistaMCavalloGMaintenance therapy in non-small cell lung cancerExpert Rev Anticancer Ther2015157 839 84626027675
   PubMed Web of Science ®Google Scholar
• Schmid-BindertGMaintenance therapy in non-small-cell lung cancerTransl Lung Cancer Res201212 105 11025806166
   PubMedGoogle Scholar
• GridelliCde MarinisFDi MaioMMaintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyLung Cancer2012763 269 27922266040
   PubMed Web of Science ®Google Scholar
• CaiHLinYLiWLiXMaintenance treatment with different strategies in advanced non-small-cell lung cancer: a systematic review and meta-analysisClin Lung Cancer2013144 333 34123276822
   PubMed Web of Science ®Google Scholar
• BeheraMOwonikokoTKChenZSingle agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysisLung Cancer2012772 331 33822546678
   PubMed Web of Science ®Google Scholar
• PetrelliFBorgonovoKCabidduMBarniSErlotinib as maintenance therapy in patients with advanced non-small cell lung cancer: a pooled analysis of three randomized trialsAnticancer Drugs20112210 1010 101921970852
   PubMed Web of Science ®Google Scholar
• WangQHuangHZengXMaYZhaoXHuangMSingle-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trialsPeerJ20164 e255027781159
   PubMed Web of Science ®Google Scholar
• HuXPuKFengXRole of gemcitabine and pemetrexed as maintenance therapy in advanced NSCLC: a systematic review and meta-analysis of randomized controlled trialsPLoS One2016113 e014924726954503
   PubMed Web of Science ®Google Scholar
• ZhangCHuangCWangJWangXLiKMaintenance or consolidation therapy for non-small-cell lung cancer: a meta-analysis involving 5841 subjectsClin Lung Cancer2015165 e15 e2325676720
   PubMed Web of Science ®Google Scholar
• LeeJEChungCUUpdate on the evidence regarding maintenance therapyTuberc Respir Dis2014761 1 7
   PubMedGoogle Scholar
• LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationBMJ2009339 b270019622552
   PubMed Web of Science ®Google Scholar
• ZintzarasEIoannidisJPHeterogeneity testing in meta-analysis of genome searchesGenet Epidemiol2005282 123 13715593093
   PubMed Web of Science ®Google Scholar
• MoherDPhamBJonesADoes quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet19983529128 609 6139746022
   PubMed Web of Science ®Google Scholar
• ButtsCSocinskiMAMitchellPLSTART trial teamTecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trialLancet Oncol2014151 59 6824331154
   PubMed Web of Science ®Google Scholar
• BarlesiFScherpereelAGorbunovaVMaintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trialAnn Oncol2014255 1044 105224585722
   PubMed Web of Science ®Google Scholar
• Paz-AresLGde MarinisFDediuMPARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerJ Clin Oncol20133123 2895 290223835707
   PubMed Web of Science ®Google Scholar
• JohnsonBEKabbinavarFFehrenbacherLATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerJ Clin Oncol20133131 3926 393424101054
   PubMed Web of Science ®Google Scholar
• BarlesiFScherpereelARittmeyerARandomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089)J Clin Oncol20133124 3004 301123835708
   PubMed Web of Science ®Google Scholar
• Paz-AresLde MarinisFDediuMMaintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trialLancet Oncol2012133 247 25522341744
   PubMed Web of Science ®Google Scholar
• CappuzzoFCiuleanuTStelmakhLSATURN investigatorsErlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 studyLancet Oncol2010116 521 52920493771
   PubMed Web of Science ®Google Scholar
• RossiADi MaioMChiodiniPCarboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient dataJ Clin Oncol20123014 1692 169822473169
   PubMed Web of Science ®Google Scholar
• LuSYuYChenZYeXLiZNiuXMaintenance therapy improves survival outcomes in patients with advanced non-small cell lung cancer: a meta-analysis of 14 studiesLung20151935 805 81426119960
   PubMed Web of Science ®Google Scholar
• YuanDMWeiSZLuYLSingle-agent maintenance therapy in non-small cell lung cancer: a systematic review and meta-analysisChin Med J (Engl)201212517 3143 314922932196
   PubMed Web of Science ®Google Scholar
• RossiAGarassinoMCCinquiniMMaintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysisLung Cancer2010702 119 12820188431
   PubMed Web of Science ®Google Scholar
• GridelliCde MarinisFThomasMFinal efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III studyJ Thorac Oncol201497 991 99724926544
   PubMed Web of Science ®Google Scholar